Asthma and menopause

Monaldi Archives for Chest Disease - Pulmonary Series

Volumn 67, Issue 3, 2007, Pages 125-127

  Bellia, V ^a   Augugliaro, G ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; BECLOMETASONE; CORTICOSTEROID; ESTRADIOL; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN F2 ALPHA; SEX HORMONE;

AGE DISTRIBUTION; ARACHIDONIC ACID METABOLISM; ASTHMA; ATOPY; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC SINUSITIS; CORTICOSTEROID INDUCED OSTEOPOROSIS; CORTICOSTEROID THERAPY; DIFFERENTIAL DIAGNOSIS; DISEASE EXACERBATION; DRUG MEGADOSE; DRUG SAFETY; EARLY DIAGNOSIS; EDITORIAL; EOSINOPHIL COUNT; ESTRADIOL BLOOD LEVEL; FRAGILITY FRACTURE; GENDER BIAS; HORMONAL REGULATION; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; RECURRENT DISEASE; SCREENING TEST;

EID: 35948930686     PISSN: 11220643     EISSN: 2465101X     Source Type: Journal    
DOI: 10.4081/monaldi.2007.482     Document Type: Editorial

References (28)

1. De Marco R, Locatelli F, Sunyer J, et al. Differences in incidence of reported asthma related to age in men and women. A retrospective analysis of the data of the European Respiratory Health Survey. Am J Respir Crit Care Med. 2000; 162: 68-74.
2. Skobeloff EM, Spivey WH, St Clair SS, et al. The influence of age and sex on asthma admissions. JAMA 1992; 268: 3437-3440.
3. Eliasson O. The male-female ratio of hospital admissions for asthma. Am Rev Resp Dis 1985; 131: A110.
4. Redline S, Gold D. Challenges in interpreting gender differences in asthma. Am J Respir Crit Care Med 1994; 150: 1219-1221.
5. Paoletti P, Carrozzi L, Viegi G, et al. Distribution of bronchial responsiveness in a general population: effect of sex, age, smoking, and level of pulmonary function. Am J Respir Crit Care Med 1995; 151: 1770-1777.
6. Bonner JR. The epidemiology and natural history of asthma. Clin Chest Med 1984; 5: 557-565.
7. Balzano G, Fuschillo S, Melillo G, Bonini S. Asthma and sex hormones. Allergy 2001; 56: 13-20.
8. Franchi AM, Gimeno MF, Gimeno AL. Estradiol-17-beta enhances the formation of (3H)-PGF2alpha from (3H)-PGE2 in the uterus isolated from ovariectomized raits. Prostaglandins 1985; 29: 773-783.
9. Durwod BJ. Concomitant problems with asthma. Ala J Med Sci 1985; 22: 393-95.
10. Myers JR, Sherman CB. Should supplemental estrogens be used as steroid-sparing agents in asthmatic women? Chest 1994; 106: 318-9.
11. Ballard K. Women's use of hormone replacement therapy for disease prevention: results of a community survey. Br J Gen Pract 2002; 52: 835-837.
12. Fletcher SW, Colditz GA. Failure of estrogen plus progestin therapy for prevention. JAMA 2002; 288: 366-368.
13. Dallongeville J, Marecaux N, Isorez D, et al. Multiple coronary heart disease risk factors are associated with menopause and influenced by substitutive hormonal therapy in a cohort of French women. Atherosclerosis 1995; 118 (1): 123-33.
14. Glazier MG, Bowman MA. A review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy. Arch Intern Med 2001; 161: 1161-72.
15. Troisi RJ, Speizer FE, Willett WC, et al. Menopause, postmenopausal estrogen preparations, and the risk of adult onset asthma. Am J Respir Crit Care Med 1995; 152: 1183-1188.
16. Lieberman D, Kopernik G, Porath A, et al. Sub-clinical worsening of bronchial asthma during estrogen replacement therapy in asthmatic post-menopausal women. Maturitas. 1995; 21: 153-57.
17. Hepburn MJ, Dooley DP, Morris MJ. The effects of estrogen replacement therapy on airway function in postmenopausal, asthmatic women. Arch Intern Med 2001; 161: 2717-20.
18. Siris ES, Miller PD, Barrett-Connor E, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA 2001; 286: 2815-2822.
19. Goldstein MF, Fallon JJ Jr, Harning R. Chronic glucocorticoid therapy-induced osteoporosis in patients with obstructive lung disease. Chest 1999; 116: 1733-1749.
20. Fujita K, Kasayama S, Hashimoto J, et al. Inhaled corticosteroids reduce bone mineral density in early postmenopausal but not premenopausal asthmatic women. J Bone Miner Res 2001; 16: 782-7.
21. From the Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2006. Available from: http:// www.ginasthma.org (last access 10/10/07)
22. Balzano G, Fuschillo S, De Angelis E, et al. Persistent airway inflammation and high exacerbation rate in asthma that starts at menopause. Monaldi Arch Chest Dis 2007; 67: 3, 135-141.
23. Kitch BT, Levy BD, Fanta CH. Late onset asthma: epidemiology, diagnosis and treatment. Drugs Aging 2000; 17: p85-97.
24. Dixon AE, Kaminsky DA, Holbrook JT, Wise RA, Shade DM, Irvin CG. Allergic rhinitis and sinusitis in asthma: differential effects on symptoms and pulmonary function. Chest 2006; 130: 429-35.
25. ten Brinke A, Sterk PJ, Masclee AA, et al. Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir J 2005; 26: 812-818.
26. Bacci E, Cianchetti S, Bartoli M, et al. Low sputum eosinophils predict the lack of response to beclomethasone in symptomatic asthmatic patients. Chest 2006; 129: 565-572.
27. Little SA, Chalmers GW, MacLeod KJ, et al. Non-invasive markers of airway inflammation as predictors of oral steroid responsiveness in asthma. Thorax 2000; 55: 232-234.
28. Bellia V, Battaglia S, Catalano F, et al. Aging and disability affect misdiagnosis of COPD in elderly asthmatics: the SARA study. Chest 2003; 123: 1066-72.